The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: A multicenter non-blinded randomized noninferiority trial.
Open accessAbstract
Background In patients with severe sepsis, no randomized clinical trial has tested the concept of de-escalation of empirical antimicrobial therapy. This study aimed to compare the de-escalation strategy with the continuation of an appropriate empirical treatment in those patients. Methods This was a multicenter non-blinded randomized noninferiority trial of patients with severe sepsis who were randomly assigned to de-escalation or continuation of empirical antimicrobial treatment. Recruitment began in February 2012 and ended in April 2013 in nine intensive care units (ICUs) in France. Patients with severe sepsis were assigned to de-escalation (n = 59) or continuation of empirical antimicrobial treatment (n = 57). The primary outcome was to measure the duration of ICU stay. We defined a noninferiority margin of 2 days. If the lower boundary of the 95 % confidence interval (CI) for the difference in patients assigned to the de-escalation group was less than 2 days, as compared with that of patients assigned to the continuation group, de-escalation was considered to be noninferior to the continuation strategy. Secondary outcomes included mortality at 90 days, occurrence of organ failure, number of superinfections, and number of days with antibiotics during the ICU stay. Results The median duration of ICU stay was 9 [interquartile range (IQR) 5-22] days in the de-escalation group and 8 [IQR 4-15] days in the continuation group, respectively (P = 0.71). The mean difference was 3.4…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We identified direct evidence from 13 studies (1968 patients) [277], including 1 RCT [278]. In our meta-analysis, we observed improved short-term mortality in patients who were de-escalated (RR 0.72; 95% CI 0.57–0.91) (Supplementary Appendix 2).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [278]
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Piaggio, G., Elbourne, D. R., Pocock, S. J., Evans, S. J. W., Altman, D. G., & CONSORT Group, F. T. (2012) · JAMA · doi:10.1001/jama.2012.87802 · Cited by 2,428
Hooton, T. M., Bradley, S. F., Cardenas, D. D., Colgan, R., Geerlings, S. E., Rice, J. C., Saint, S., Schaeffer, A. J., Tambayh, P. A., Tenke, P., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/650482 · Cited by 2,099 · cited 10×
“The choice of antibiotics was based on international guidelines [3, 15–18].”
BackgroundMethodInfluentialIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 9×
“The durations of ICU stay were 14 [9–31] days and 15 [8–21] days in the de-escalation group and the continuation group, respectively (P = 0.”
BackgroundInfluentialPractice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602 · cited 10×
“The choice of antibiotics was based on international guidelines [3, 15–18].”
BackgroundMethodInfluentialSolomkin, J. S., Mazuski, J. E., Bradley, J. S., Rodvold, K. A., Goldstein, E. J. C., Baron, E. J., O'Neill, P. J., Chow, A. W., Dellinger, E. P., Eachempati, S. R., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649554 · Cited by 1,558
Drotrecogin Alfa (Activated) in Adults with Septic Shock
Ranieri, V. M., Thompson, B. T., Barie, P. S., Dhainaut, J.-F., Douglas, I. S., Finfer, S., Gårdlund, B., Marshall, J. C., Rhodes, A., Artigas, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202290 · Cited by 1,309 · cited 10×
“The durations of ICU stay were 14 [9–31] days and 15 [8–21] days in the de-escalation group and the continuation group, respectively (P = 0.”
BackgroundMethodInfluentialCalandra, T., & Cohen, J. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000168253.91200.83 · Cited by 839
Garnacho-Montero, J., Gutiérrez-Pizarraya, A., Escoresca-Ortega, A., Corcia-Palomo, Y., Fernández-Delgado, E., Herrera-Melero, I., Ortiz-Leyba, C., & Márquez-Vácaro, J. A. (2014) · Intensive Care Medicine · doi:10.1007/s00134-013-3077-7 · Cited by 389
On the theory of order statistics
Rényi, A. (1953) · Acta Mathematica Academiae Scientiarum Hungaricae · doi:10.1007/bf02127580 · Cited by 371
De-escalation therapy in ventilator-associated pneumonia*
Rello, J., Vidaur, L., Sandiumenge, A., Rodríguez, A., Gualis, B., Boque, C., & Diaz, E. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145997.10438.28 · Cited by 249 · cited 10×
“0 13 [1–375] 18.”
BackgroundMethodInfluentialRetamar, P., Portillo, M. M., López-Prieto, M. D., Rodríguez-López, F., de Cueto, M., García, M. V., Gómez, M. J., del Arco, A., Muñoz, A., Sánchez-Porto, A., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00462-11 · Cited by 239 · cited 9×
“The durations of ICU stay were 14 [9–31] days and 15 [8–21] days in the de-escalation group and the continuation group, respectively (P = 0.”
BackgroundInfluentialEmpirical antimicrobial therapy of septic shock patients: Adequacy and impact on the outcome*
Leone, M., Bourgoin, A., Cambon, S., Dubuc, M., Albanèse, J., & Martin, C. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050298.59549.4a · Cited by 212 · cited 10×
“5 [6–13] in the de-escalation group and continuation group, respectively (P = 0.”
BackgroundMethodInfluentialSelf-citationSelection bias in observational and experimental studies
Ellenberg, J. H. (1994) · Statistics in Medicine · doi:10.1002/sim.4780130518 · Cited by 178 · cited 10×
“The durations of ICU stay were 14 [9–31] days and 15 [8–21] days in the de-escalation group and the continuation group, respectively (P = 0.”
BackgroundMethodInfluentialMartín‐Loeches, I., Deja, M., Koulenti, D., Dimοpoulos, G., Marsh, B. J., Torres, A., Niederman, M. S., Rello, J., & EU-VAP Study Investigators (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2808-5 · Cited by 147
Mokart, D., Slehofer, G., Lambert, J., Sannini, A., Chow‐Chine, L., Brun, J. P., Berger, P., Duran, S., Faucher, M., Blache, J. L., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-3148-9 · Cited by 137 · cited 10×
“5 [6–13] in the de-escalation group and continuation group, respectively (P = 0.”
BackgroundMethodInfluentialDe-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock
Silva, B. N., Andriolo, R. B., Atallah, Á. N., & Salomão, R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007934.pub3 · Cited by 128 · cited 10×
“5 [6–13] in the de-escalation group and continuation group, respectively (P = 0.”
BackgroundInfluentialMorel, J., Casoetto, J., Jospé, R., Aubert, G., Terrana, R., Dumont, A., Molliex, S. B., & Auboyer, C. (2010) · Critical Care · doi:10.1186/cc9373 · Cited by 126 · cited 10×
“5 [6–13] in the de-escalation group and continuation group, respectively (P = 0.”
BackgroundMethodInfluentialAntibiotic strategies in severe nosocomial sepsis: Why do we not de-escalate more often?*
Heenen, S., Jacobs, F., & Vincent, J. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182416ecf · Cited by 102
De-escalation therapy in ventilator-associated pneumonia
Niederman, M. S. (2006) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000244126.84989.a2 · Cited by 69 · cited 10×
“5 [6–13] in the de-escalation group and continuation group, respectively (P = 0.”
BackgroundInfluentialRecognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit
Maragakis, L. L. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e6cbc5 · Cited by 64
Hospital-acquired pneumonia and de-escalation of antimicrobial treatment
Kollef, M. H. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00029 · Cited by 55 · cited 10×
“At the bedside, de-escalation consists either in eliminating one of the antibiotics of the prescribed combination or, whenever possible, using a beta-lactam antibiotic with a narrower spectrum of activity [4].”
BackgroundMethodInfluentialTrials which randomize practices II: sample size
Kerry, S. (1998) · Family Practice · doi:10.1093/fampra/15.1.84 · Cited by 50 · cited 9×
“The durations of ICU stay were 14 [9–31] days and 15 [8–21] days in the de-escalation group and the continuation group, respectively (P = 0.”
BackgroundInfluentialLéone, M., Malavieille, F., Papazian, L., Meyssignac, B., Cassir, N., Textoris, J., Antonini, F., Scola, B. L., Martin, C., Allaouchiche, B., et al. (2013) · Critical Care · doi:10.1186/cc12849 · Cited by 36 · cited 8×
“The durations of ICU stay were 14 [9–31] days and 15 [8–21] days in the de-escalation group and the continuation group, respectively (P = 0.”
BackgroundResultInfluentialSelf-citationShime, N., Kosaka, T., & Fujita, N. (2012) · Infection · doi:10.1007/s15010-012-0388-5 · Cited by 32 · cited 10×
“5 [6–13] in the de-escalation group and continuation group, respectively (P = 0.”
BackgroundMethodInfluentialGarcin, F., Léone, M., Antonini, F., Charvet, A., Albanèse, J., & Martin, C. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1660-8 · Cited by 30 · cited 8×
“The durations of ICU stay were 14 [9–31] days and 15 [8–21] days in the de-escalation group and the continuation group, respectively (P = 0.”
BackgroundInfluentialSelf-citationNon-antibiotic treatment for bacterial infections: how to validate chance findings
Leibovici, L. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02754.x · Cited by 13 · cited 9×
“The durations of ICU stay were 14 [9–31] days and 15 [8–21] days in the de-escalation group and the continuation group, respectively (P = 0.”
BackgroundInfluential
Cited by
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“associated with equivalent or superior clinical outcomes in sepsis and septic shock [54, 190–192]; despite this, at least one study has indicated an increased frequency of superinfection and longer ICU stay [192].”
ResultSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
“There was no difference in mortality or ICU length of stay [352].”
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Metadata
- Authors
- Leone, M., Bechis, C., Baumstarck, K., Lefrant, J.-Y., Albanèse, J., Jaber, S., Lepape, A., Constantin, J.-M., Papazian, L., Bruder, N., Allaouchiche, B., Bézulier, K., Antonini, F., Textoris, J., Martin, C., & For the AZUREA Network Investigators
- Affiliations
- Hôpital Nord (FR)
- Aix-Marseille Université (FR)
- Centre Hospitalier Universitaire de Nîmes (FR)
- Hôpital de la Conception (FR)
- Inserm (FR)
- Hospices Civils de Lyon (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- Centre National de la Recherche Scientifique (FR)
- Hôpital de la Timone (FR)
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2014-08-05
- Volume
- 40
- Issue
- 10
- Pages
- 1399-1408
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2053430308
- Cited by
- 243
- References
- 32
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 18 · 2023: 18 · 2022: 17 · 2021: 18 · 2020: 28 · 2019: 27 · 2018: 18 · 2017: 22 · 2016: 32 · 2015: 14 · 2014: 5
- FWCI
- 18.32
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-10-07)
- Open access
- green
- hal.umontpellier.fr
- Licence
- other-oa
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- severe sepsis, antibiotic de-escalation, empirical antimicrobial therapy, ICU length of stay, superinfection, antibiotic duration, mortality, organ failure
- MeSH terms
- Aged, Anti-Bacterial Agents, Female, France, Humans, Intensive Care Units, Length of Stay, Male, Microbial Sensitivity Tests, Middle Aged, Multivariate Analysis, Linear Models, Proportional Hazards Models, Sepsis, Withholding Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.